Miami, FL · Health Care · Form D filed Sep 8, 2026
Klothea Bio, Inc. raised $6.9M
Klothea Bio, Inc. is a health care company based in Miami, Florida. In an amended Form D filed with the SEC on September 8, 2026, it reported raising $6,885,000 from 22 investors as part of an offering of up to $10,385,000. The first sale in the offering took place on October 11, 2024.
- 2nd Form D since 2024. Earlier new notices: Oct 28, 2024. All filings on EDGAR
- Still raising. $3.5M of the $10.4M offering was still unsold at filing.
$6.9M raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Oct 28, 2024 | $6.9M | $10.4M | 22 |
Placement agent: Finalis Securities, LLC
Lead score
37 out of 100
early raise still raising budget to spend young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $6,885,000
- Offering size
- $10,385,000
- Investors so far
- 22
- First sale
- October 11, 2024
- Securities offered
- Debt, Options or warrants, Securities issuable on exercise or conversion
- Exemption claimed
- Rule 506(b)
- Industry
- Health Care
- Headquarters
- Miami, Florida
- Incorporated
- Delaware, 2024
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D/A (amendment) | $6,885,000 | $10,385,000 | 22 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 7, 2026 · Health Care funding in Florida · September 2026 funding report
Similar raises
SC River Inv LLC
Miami, FL · filed Oct 16First Form D
Remitian Inc.
Miami, FL · filed Oct 15First Form DStill raising
Voice Eval Systems, Inc.
Miami, FL · filed Oct 152nd Form D since 2025
Cahero Korva Holding LLC
Miami, FL · filed Oct 14First Form D
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Curadel Surgical Innovations, Inc.
Bonita Springs, FL · filed Oct 134th Form D since 2023Still raising
BioStem Technologies, Inc.
Pompano Beach, FL · filed Oct 9
BioStem Technologies® produces innovative perinatal tissue-based allografts, including VENDAJE®, VENDAJE AC® and VENDAJE® optic.
7th Form D since 2016
Lev 18, Inc.
Surfside, FL · filed Oct 9First Form D